Miravast

Stallion Laboratories Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 1425b0bfcab60063
Drug Approval Philippines Name: Miravast
Product Name: Miravast
Registration Number: DRP-2511-03
Brand Name: Miravast
Generic Name: Atorvastatin (as calcium) + Amlodipine (as besilate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 5 mg/10 mg
Manufacturer: Stallion Laboratories Pvt. Ltd.
Importer: Ambica International Corp.
Distributor: Miraculin Pharma, Inc.
Issuance Date: 28 February 2023
Expiry Date: 07 October 2028
Pharmacologic Category: HMG-CoA Reductase Inhibitor / Calcium Channel Blocker
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1425b0bfcab60063

Type

Standard